366 results
A new study evaluates whether nighttime dosing of antihypertensive drugs exerts better blood pressure control and reduces cardiovascular outcomes.
With all the media attention on COVID-19 caused by a novel coronavirus, it’s important not to forget about the more common causes of respiratory infections and pneumonia.
Get to know Bonnie W. Johnson, Opportunity Manager on the Innovations and Evidence-Based Medicine Development Team at EBSCO Information Services.
An outbreak of a new coronavirus strain is causing panic around the world. Here’s what we know about 2019-nCoV.
The FDA has recently approved a second drug for pre-exposure prophylaxis (PrEP) for prevention of HIV. Here’s what we know.
Find out about EBSCO’s ongoing improvements to CKN, which have helped Queensland clinicians have better access, visibility and usage of patient-critical information resources.
Colleen Seeber-Combs, MSN, RN, is EBSCO’s Nursing and Allied Health Section Editor, Medical-Surgical. Learn how her expertise helps EBSCO create superior nursing and allied health content.
Members of the EBM Focus editorial team at DynaMed® select their top clinical trial summaries of 2019.
Hypertension is a common medical problem that almost all physicians must deal with, but what’s the rational blood pressure target?
EBM Focus: Statin’ Young– Benefit of Starting Statins in Children with Familial Hypercholesterolemia
A new 20-year follow-up study suggests that long-term statin therapy starting in childhood may prevent cardiovascular disease in patients with familial hypercholesterolemia.